179 related articles for article (PubMed ID: 25239884)
21. Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines.
Li ZY; Li QZ; Chen L; Chen BD; Wang B; Zhang XJ; Li WP
Neurochem Res; 2016 Dec; 41(12):3192-3205. PubMed ID: 27632183
[TBL] [Abstract][Full Text] [Related]
22. Mullerian-inhibiting substance induces Gro-beta expression in breast cancer cells through a nuclear factor-kappaB-dependent and Smad1-dependent mechanism.
Gupta V; Yeo G; Kawakubo H; Rangnekar V; Ramaswamy P; Hayashida T; MacLaughlin DT; Donahoe PK; Maheswaran S
Cancer Res; 2007 Mar; 67(6):2747-56. PubMed ID: 17363596
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms underlying differential expression of interleukin-8 in breast cancer cells.
Freund A; Jolivel V; Durand S; Kersual N; Chalbos D; Chavey C; Vignon F; Lazennec G
Oncogene; 2004 Aug; 23(36):6105-14. PubMed ID: 15208657
[TBL] [Abstract][Full Text] [Related]
24. SMAR1 forms a ternary complex with p53-MDM2 and negatively regulates p53-mediated transcription.
Pavithra L; Mukherjee S; Sreenath K; Kar S; Sakaguchi K; Roy S; Chattopadhyay S
J Mol Biol; 2009 May; 388(4):691-702. PubMed ID: 19303885
[TBL] [Abstract][Full Text] [Related]
25. Protein kinase Cdelta activates RelA/p65 and nuclear factor-kappaB signaling in response to tumor necrosis factor-alpha.
Lu ZG; Liu H; Yamaguchi T; Miki Y; Yoshida K
Cancer Res; 2009 Jul; 69(14):5927-35. PubMed ID: 19549902
[TBL] [Abstract][Full Text] [Related]
26. Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis.
Liu Y; Smith PW; Jones DR
Mol Cell Biol; 2006 Dec; 26(23):8683-96. PubMed ID: 17000776
[TBL] [Abstract][Full Text] [Related]
27. Synergistic transcriptional activation of the IL-8 gene by NF-kappa B p65 (RelA) and NF-IL-6.
Kunsch C; Lang RK; Rosen CA; Shannon MF
J Immunol; 1994 Jul; 153(1):153-64. PubMed ID: 8207232
[TBL] [Abstract][Full Text] [Related]
28. Krüppel-associated box-associated protein 1 negatively regulates TNF-α-induced NF-κB transcriptional activity by influencing the interactions among STAT3, p300, and NF-κB/p65.
Kamitani S; Togi S; Ikeda O; Nakasuji M; Sakauchi A; Sekine Y; Muromoto R; Oritani K; Matsuda T
J Immunol; 2011 Sep; 187(5):2476-83. PubMed ID: 21810609
[TBL] [Abstract][Full Text] [Related]
29. Coordinated regulation of p53 apoptotic targets BAX and PUMA by SMAR1 through an identical MAR element.
Sinha S; Malonia SK; Mittal SP; Singh K; Kadreppa S; Kamat R; Mukhopadhyaya R; Pal JK; Chattopadhyay S
EMBO J; 2010 Feb; 29(4):830-42. PubMed ID: 20075864
[TBL] [Abstract][Full Text] [Related]
30. Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-kappaB activation.
Samant RS; Clark DW; Fillmore RA; Cicek M; Metge BJ; Chandramouli KH; Chambers AF; Casey G; Welch DR; Shevde LA
Mol Cancer; 2007 Jan; 6():6. PubMed ID: 17227585
[TBL] [Abstract][Full Text] [Related]
31. Nuclear matrix-associated protein SMAR1 regulates alternative splicing via HDAC6-mediated deacetylation of Sam68.
Nakka KK; Chaudhary N; Joshi S; Bhat J; Singh K; Chatterjee S; Malhotra R; De A; Santra MK; Dilworth FJ; Chattopadhyay S
Proc Natl Acad Sci U S A; 2015 Jun; 112(26):E3374-83. PubMed ID: 26080397
[TBL] [Abstract][Full Text] [Related]
32. Mechanism of IFN-beta-mediated inhibition of IL-8 gene expression in astroglioma cells.
Nozell S; Laver T; Patel K; Benveniste EN
J Immunol; 2006 Jul; 177(2):822-30. PubMed ID: 16818736
[TBL] [Abstract][Full Text] [Related]
33. SMAR1 favors immunosurveillance of cancer cells by modulating calnexin and MHC I expression.
Alam A; Taye N; Patel S; Thube M; Mullick J; Shah VK; Pant R; Roychowdhury T; Banerjee N; Chatterjee S; Bhattacharya R; Roy R; Mukhopadhyay A; Mogare D; Chattopadhyay S
Neoplasia; 2019 Oct; 21(10):945-962. PubMed ID: 31422285
[TBL] [Abstract][Full Text] [Related]
34. Nuclear matrix protein SMAR1 represses c-Fos-mediated HPV18 E6 transcription through alteration of chromatin histone deacetylation.
Chakraborty S; Das K; Saha S; Mazumdar M; Manna A; Chakraborty S; Mukherjee S; Khan P; Adhikary A; Mohanty S; Chattopadhyay S; Biswas SC; Sa G; Das T
J Biol Chem; 2014 Oct; 289(42):29074-85. PubMed ID: 25157104
[TBL] [Abstract][Full Text] [Related]
35. The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells.
Kim DW; Gazourian L; Quadri SA; Romieu-Mourez R; Sherr DH; Sonenshein GE
Oncogene; 2000 Nov; 19(48):5498-506. PubMed ID: 11114727
[TBL] [Abstract][Full Text] [Related]
36. Chromatin remodeling protein SMAR1 regulates adipogenesis by modulating the expression of PPARγ.
Pant R; Alam A; Choksi A; Shah VK; Firmal P; Chattopadhyay S
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Dec; 1866(12):159045. PubMed ID: 34450266
[TBL] [Abstract][Full Text] [Related]
37. CHFR, a potential tumor suppressor, downregulates interleukin-8 through the inhibition of NF-kappaB.
Kashima L; Toyota M; Mita H; Suzuki H; Idogawa M; Ogi K; Sasaki Y; Tokino T
Oncogene; 2009 Jul; 28(29):2643-53. PubMed ID: 19448676
[TBL] [Abstract][Full Text] [Related]
38. Respiratory syncytial virus-inducible BCL-3 expression antagonizes the STAT/IRF and NF-kappaB signaling pathways by inducing histone deacetylase 1 recruitment to the interleukin-8 promoter.
Jamaluddin M; Choudhary S; Wang S; Casola A; Huda R; Garofalo RP; Ray S; Brasier AR
J Virol; 2005 Dec; 79(24):15302-13. PubMed ID: 16306601
[TBL] [Abstract][Full Text] [Related]
39. BRMS1 contributes to the negative regulation of uPA gene expression through recruitment of HDAC1 to the NF-kappaB binding site of the uPA promoter.
Cicek M; Fukuyama R; Cicek MS; Sizemore S; Welch DR; Sizemore N; Casey G
Clin Exp Metastasis; 2009; 26(3):229-37. PubMed ID: 19165610
[TBL] [Abstract][Full Text] [Related]
40. Selective repression of YKL-40 by NF-kappaB in glioma cell lines involves recruitment of histone deacetylase-1 and -2.
Bhat KP; Pelloski CE; Zhang Y; Kim SH; deLaCruz C; Rehli M; Aldape KD
FEBS Lett; 2008 Sep; 582(21-22):3193-200. PubMed ID: 18708058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
